Please Wait.....
Report
Sepsis Diagnostics: Global Markets
Market Research Report I 2022-04-22 I 114 Pages I BCC Research
Description
Report Scope:
The current report provides detailed exposure to the sepsis diagnostic market. This report highlights the current and future market potential of sepsis diagnostics, as well as a detailed analysis of market drivers, challenges and opportunities. The report also covers market projections to 2026 and market shares for key market players. It details the market share of sepsis diagnostics based on technology type, product, diagnostic method and pathogen type. The report includes company profiles of the key players, with detailed information regarding their business segments, financials, product portfolios and recent developments. The report also provides the impact of the COVID-19 pandemic on this market.
The regional market has been segmented into North America, Europe, Asia-Pacific and the Rest of the world. For market estimates, data have been provided for 2019 as the historic year and 2020 as the base year, with a forecast for 2026.
Report Includes:
- 35 data tables and 15 additional tables
- An updated overview of the global sepsis diagnostics market
- Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global market size for sepsis diagnostics, and corresponding market share analysis by product, technology type, diagnostic method, test type, pathogen, end user and geographic region
- Highlights the current and future market potential of sepsis diagnostics along with a detailed analysis of the drivers, challenges, and opportunities in the market
- Identification of promising new products and technologies still in the development and assess the probability that they will be commercialized successfully in the next five years
- Discussion of the COVID-19 implications on the market for sepsis clinical diagnostics and research studies
- Information pertaining to the companies best positioned to meet this demand owing to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
- Insight into the recent industry structure, current competitive scenario, R&D activities, product launch strategies and company value share analysis based on their segmental revenues
- Descriptive company profiles of the leading global players, including Abbott Laboratories, Bruker Corp., Roche Diagnostics Corp., Siemens Healthineers AG and Thermo Fisher Scientific Inc.
Executive Summary
Summary:
Sepsis is a life-threatening conditionmarked by severe organ dysfunction. According to theWorld Health Organization's (WHO) GlobalReport on the Epidemiology and Burden of Sepsis, therewere 49 million cases and 11 million sepsis-related deaths in 2017, accounting for nearly 20% of all annual global deaths. Sepsis is considered as the common pathway to death for severaldiseases, including infectious diseases. In the recent report on sepsis, the WHO observed that even non-communicable or chronic diseases and injuries can also lead to sepsis. Studies indicate that the incidence of sepsis is increasing, but the mortality rate is decreasing. The burden of the disease, however, is very high in low-and middleincome countrieswith poor healthcare infrastructures. Elderly patients, neonates and immunocompromised patients are at high risk of sepsis.
Sepsis is also associatedwith high economic burden and is the most expensive condition forhospitalized patients. For this reason, theWHO andWorld Health Assembly (WHA) have adopted a resolution in 2017 to improve, prevent, diagnose andmanage sepsis.
There is no specific laboratory test to diagnose sepsis. The current diagnosis is based on various technologies, including microbiological tests,moleculardiagnostics and biomarkers.Microbiological tests are the most preferredmethod. Despite advances in the molecular diagnostic methods, blood culture is considered the gold standard for the diagnosis of sepsis.Molecular techniques have been limited due to high cost and the need for a skilled workforce.Microbial identification is restricted to the specified panels used in the technique. The blood culture method has both advantages and limitations. Blood cultures are time consuming and may result in false negatives. It is for this reason that there is
high need for a rapid and accurate diagnostic method. Thus, there is scope forpoint-of-care tests that would be helpful in bedside sepsis diagnosis. Rapid diagnosis and early treatment lead to betterpatient outcomes, with survival rates are as high as 80%. Delay in diagnosis also leads to increased risk of antimicrobial resistance, as patientswith sepsis are initially startedwith antimicrobials. It is based on the culture results that physicians start with targeted antimicrobials and look into escalation or deescalation of the ongoing antimicrobial therapy.
Thus, increasing prevalence, awareness and various government initiativeswill lead to growth in the sepsis diagnostic market. The market has also witnessed technologicaladvancementswith novel instruments that usewhole blood fordetection and do not rely on positive blood cultures. Research is also focused on studying the benefit of biomarker combinations, as each biomarker represents a different aspect of sepsis andwould help in early detection. Research is focused on microfluidics, machine learning and artificial intelligence tools for rapid diagnosis.
The global market for sepsis diagnosticswas estimated to be REDACTED in 2020, and the market is expected to increase to nearly REDACTED through 2026, growing at a compound annual growth rate (CAGR) of REDACTED during the forecast period.Majorplayers in the market include BioMerieux, Becton, Dickinson and Company, DanaherCorporation, Thermo Fisher Scientific, T2 Biosystems, Luminex, Roche Diagnostics, BrukerCorporation, Abbott Laboratories and Immunexpress.
In this report, the market is segmented based on technology, product,method, test, pathogen, end user and region. The North Americanmarket currently holds the highestmarket share, followed by Europe.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Technology Background
Introduction
Causes
Risk Factors
Symptoms
Pathophysiology
Endothelial Dysfunction
Coagulopathy
Cardiovascular Dysfunction
Cellular Dysfunction
Epidemiology and Economic Burden
Diagnosis and Treatment
Regulatory Scenario
Regulations in North America
European Regulations
Chapter 4 Market Dynamics
Factors Affecting the Sepsis Diagnostic Market
Market Drivers
Increasing Incidence of Infectious Diseases
Rising Aging Population and Increasing Incidence of Chronic Diseases
Increasing Government Initiatives
Technological Developments
Market Restraints
High Cost of Instruments and Lack of Skilled Workforce
Opportunities
Demand for Rapid and Accurate Diagnostic Tool
Chapter 5 Impact of COVID-19
Introduction
Outbreak
COVID-19 Symptoms
COVID-19 Progression
Incubation Period
Epidemiology
Collaboration Between Organizations and Governments
Spread of Disease
Impact of COVID-19 on the Sepsis Diagnostic Market
Chapter 6 Sepsis Diagnostic Market by Technology
Global Sepsis Diagnostic Market by Technology
Microbiological Tests
Immunoassays
Molecular Diagnostics
Others
Chapter 7 Sepsis Diagnostic Market by Product
Assays and Reagents
Culture Media
Instruments
Software
Chapter 8 Sepsis Diagnostic Market by Method
Conventional Diagnostics
Automated Diagnostics
Chapter 9 Sepsis Diagnostic Market by Test Type
Laboratory Tests
Point-of-Care Tests
Chapter 10 Sepsis Diagnostic Market by Pathogen Type
Bacterial Sepsis
Fungal Sepsis
Others
Chapter 11 Sepsis Diagnostic Market by End User
Hospitals and Clinics
Diagnostic Centers
Academic and Research Institutions
Chapter 12 Sepsis Diagnostic Market by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 13 Competitive Landscape and Analysis of Market Opportunities
Recent Developments
Mergers, Acquisitions and Collaborations
Sepsis Diagnostic Company Market Shares
Chapter 14 Company Profiles
ABBOTT LABORATORIES
AXIS-SHIELD DIAGNOSTICS LTD.
BECTON, DICKINSON & COMPANY
BIOMERIEUX
BRUKER CORP.
DANAHER
EKF DIAGNOSTICS HOLDINGS PLC
IMMUNEXPRESS
LUMINEX CORP.
QIAGEN NV
ROCHE DIAGNOSTICS CORP.
SEEGENE
SIEMENS HEALTHINEERS AG
T2 BIOSYSTEMS
THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table B : Global Sepsis Diagnostic Market, by Region, Through 2026
Summary Table A : Global Sepsis Diagnostic Market, Through 2026
Table 1 : Diagnostic Test Types and Regulation
Table 2 : COVID-19 Clinical Symptom Distribution
Table 3 : COVID-19 Confirmed Cases and Deaths, by WHO Region, April 1, 2022
Table 4 : Global Sepsis Diagnostic Market, Through 2026
Table 5 : Global Sepsis Diagnostic Market, by Technology, Through 2026
Table 6 : Global Sepsis Diagnostic Market for Microbiological Tests, by Region, Through 2026
Table 7 : Global Sepsis Diagnostic Market for Immunoassays, by Region, Through 2026
Table 8 : Global Sepsis Diagnostic Market for Molecular Diagnosis, by Region, Through 2026
Table 9 : Global Sepsis Diagnostic Market for Other Technology, by Region, Through 2026
Table 10 : Global Sepsis Diagnostic Market, by Product Type, Through 2026
Table 11 : Global Sepsis Diagnostic Market for Assays and Reagents, by Region, Through 2026
Table 12 : Global Sepsis Diagnostic Market for Culture Media, by Region, Through 2026
Table 13 : Global Sepsis Diagnostic Market for Instruments, by Region, Through 2026
Table 14 : Global Sepsis Diagnostic Market for Software, by Region, Through 2026
Table 15 : Global Sepsis Diagnostic Market, by Method Type, Through 2026
Table 16 : Global Sepsis Diagnostic Market for Conventional Methods, by Region, Through 2026
Table 17 : Global Sepsis Diagnostic Market for Automated Methods, by Region, Through 2026
Table 18 : Global Sepsis Diagnostic Market, by Test Type, Through 2026
Table 19 : Global Sepsis Diagnostic Market for Laboratory Tests, by Region, Through 2026
Table 20 : Global Sepsis Point-of-Care Test Diagnostic Market, by Region, Through 2026
Table 21 : Global Sepsis Diagnostic Market, by Pathogen Type, Through 2026
Table 22 : Global Bacterial Sepsis Market, by Region, Through 2026
Table 23 : Global Fungal Sepsis Market, by Region, Through 2026
Table 24 : Global Sepsis by Other Pathogens Market, by Region, Through 2026
Table 25 : Global Sepsis Diagnostic Market, by End User, Through 2026
Table 26 : Global Sepsis Diagnostic in Hospitals and Clinics Market, by Region, Through 2026
Table 27 : Global Sepsis Diagnostics in Diagnostic Centers Market, by Region, Through 2026
Table 28 : Global Sepsis Diagnostics in Academic and Research Institutions Market, by Region, Through 2026
Table 29 : Global Sepsis Diagnostic Market, by Region, Through 2026
Table 30 : Mergers, Acquisitions and Collaborations Portfolio, 2020-2022
Table 31 : Abbott Laboratories: Business Segment
Table 32 : Abbott Laboratories: Financials, 2018-2020
Table 33 : Becton, Dickinson & Company: Business Segment
Table 34 : Becton, Dickinson & Company: Financials, 2018-2020
Table 35 : BioMerieux SA: Sepsis Product Portfolio
Table 36 : BioMerieux SA: Financials, 2018-2020
Table 37 : Bruker Corp.: Financials, 2018-2020
Table 38 : Danaher: Business Segment
Table 39 : Danaher: Financials, 2018-2020
Table 40 : EKF Diagnostics Holdings PLC: Business Segment
Table 41 : Luminex: Product Portfolio
Table 42 : Roche Diagnostics Corp.: Product Segment
Table 43 : Roche Diagnostics Corp.: Financial Performance, 2018-2020
Table 44 : Roche Diagnostics Corp.: Key Developments
Table 45 : Siemens Healthineers AG: Business Segment
Table 46 : T2 Biosystems: Product Portfolio
Table 47 : T2 Biosystems: Key Developments
Table 48 : Thermo Fisher Scientific Inc.: Business Segments
Table 49 : Thermo Fisher Scientific Inc.: Financial Performance, 2018-2020
List of Figures
Summary Figure A : Global Sepsis Diagnostic Market, 2019-2026
Summary Figure B : Global Sepsis Diagnostic Market, by Region, 2019-2026
Figure 1 : Sepsis Definition
Figure 2 : Sepsis Pathophysiology
Figure 3 : Global Sepsis Diagnostic Market, by Technology, 2019-2026
Figure 4 : Global Sepsis Diagnostic Market Share, by Technology, 2020
Figure 5 : Global Sepsis Diagnostic Market for Microbiological Tests, by Region, 2019-2026
Figure 6 : Global Sepsis Diagnostic Market for Immunoassays, by Region, 2019-2026
Figure 7 : Global Sepsis Diagnostic Market for Molecular Diagnosis, by Region, 2019-2026
Figure 8 : Global Sepsis Diagnostic Market for Other Technology, by Region, 2019-2026
Figure 9 : Global Sepsis Diagnostic Market, by Product Type, 2019-2026
Figure 10 : Global Market Share for Sepsis Diagnostics, by Product Type, 2020
Figure 11 : Global Sepsis Diagnostic Assay and Reagent Market, by Region, 2019-2026
Figure 12 : Global Sepsis Diagnostic Market for Culture Media, by Region, 2019-2026
Figure 13 : Global Sepsis Diagnostic Market for Instruments, by Region, 2019-2026
Figure 14 : Global Sepsis Diagnostic Market for Software, by Region, 2019-2026
Figure 15 : Global Sepsis Diagnostic Market, by Method Type, 2019-2026
Figure 16 : Global Sepsis Diagnostic Market Share, by Method Type, 2020
Figure 17 : Global Sepsis Diagnostic Market for Conventional Methods, by Region, 2019-2026
Figure 18 : Global Sepsis Diagnostic Market for Automated Methods, by Region, 2019-2026
Figure 19 : Global Sepsis Diagnostic Market, by Test Type, 2019-2026
Figure 20 : Global Sepsis Diagnostic Market Share, by Test Type, 2020
Figure 21 : Global Sepsis Diagnostic Market for Laboratory Tests, by Region, 2019-2026
Figure 22 : Global Sepsis Point-of-Care Test Diagnostic Market, by Region, 2019-2026
Figure 23 : Global Sepsis Diagnostic Market, by Pathogen Type, 2019-2026
Figure 24 : Global Sepsis Diagnostics Market Share, by Pathogen Type, 2020
Figure 25 : Global Bacterial Sepsis Market, by Region, 2019-2026
Figure 26 : Global Fungal Sepsis Market, by Region, 2019-2026
Figure 27 : Global Sepsis by Other Pathogens Market, by Region, 2019-2026
Figure 28 : Global Sepsis Diagnostics Market, by End User, 2019-2026
Figure 29 : Global Sepsis Diagnostics Market Share, by End User, 2020
Figure 30 : Global Sepsis Diagnostics in Hospitals and Clinics Market, by Region, 2019-2026
Figure 31 : Global Sepsis Diagnostics in Diagnostic Centers, by Region, 2019-2026
Figure 32 : Global Sepsis Diagnostics in Academic and Research Institutions Market, by Region, 2019-2026
Figure 33 : Global Sepsis Diagnostic Market, by Region, 2019-2026
Figure 34 : Global Sepsis Diagnostic Market Share, by Region, 2020
Figure 35 : Global Sepsis Diagnostic Market Share, by Key Manufacturers and Suppliers, 2020
Figure 36 : Abbott Laboratories: Annual Revenue, 2018-2020
Figure 37 : Abbott Laboratories: Market Share, by Business Segment, 2020
Figure 38 : Abbott Laboratories: Revenue Share, by Region, 2020
Figure 39 : Abbott Laboratories: Diagnostics Segment Market Share, 2020
Figure 40 : Becton, Dickinson & Company: Annual Revenue, 2018-2020
Figure 41 : Becton, Dickinson & Company: Market Share, by Region, 2020
Figure 42 : Becton, Dickinson & Company: Market Share, by Business Segments, 2020
Figure 43 : BioMerieux SA: Annual Revenue, 2018-2020
Figure 44 : BioMerieux SA: Market Share, by Business Segment, 2020
Figure 45 : BioMerieux SA: Market Share, by Region, 2020
Figure 46 : Bruker Corp.: Annual Revenue, 2018-2020
Figure 47 : Bruker Corp.: Revenue Market Share, by Region, 2020
Figure 48 : Bruker Corp.: Market Share, by Business Segment, 2020
Figure 49 : Danaher: Annual Revenue, 2018-2020
Figure 50 : Danaher: Diagnostic Segment Market Share, by Region/Market, 2020
Figure 51 : Danaher: Market Share, by Business Segment, 2020
Figure 52 : Roche Diagnostics Corp.: Annual Revenue, 2018-2020
Figure 53 : Roche Diagnostics Corp.: Market Share, by Region, 2020
Figure 54 : Roche Diagnostics Corp.: Market Share, by Business Segment, 2020
Figure 55 : Siemens Healthineers AG: Annual Revenue, 2020 and 2021
Figure 56 : Siemens Healthineers: Market Share, by Business Segment, 2021
Figure 57 : Siemens Healthineers: Market Share, by Region, 2021
Figure 58 : T2 Biosystems: Annual Revenue, 2018-2020
Figure 59 : T2 Biosystems: Market Share, by Region, 2020
Figure 60 : T2 Biosystems: Market Share, by Products, 2020
Figure 61 : Thermo Fisher Scientific Inc.: Annual Revenue, 2018-2020
Figure 62 : Thermo Fisher Scientific Inc.: Market Share, by Region, 2020
Figure 63 : Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2021
Figure 64 : Thermo Fisher Scientific Inc.: Market Share, by Product, 2020
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security